<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type='text/xml' href='//neomorph.com/?wds_sitemap_styling=1&#038;template=sitemapBody'?><!-- SMARTCRAWL SITEMAP -->
<urlset
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	>
			<url>
<loc>https://neomorph.com/</loc>
<lastmod>2026-04-16T13:24:48+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-announces-first-patient-dosed-in-phase-1-2-trial-evaluating-neo-811-for-the-treatment-of-locally-advanced-or-metastatic-non-resectable-clear-cell-renal-cell-carcinoma/</loc>
<lastmod>2026-03-03T13:46:41+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/abbvie-and-neomorph-announce-collaboration-to-develop-molecularglue-degraders-for-oncology-and-immunology/</loc>
<lastmod>2026-03-03T14:02:48+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/biogen-and-neomorph-announce-multi-target-research-collaboration-to-discover-and-develop-molecular-glue-degraders-for-alzheimers-rare-and-immunological-diseases/</loc>
<lastmod>2026-03-03T14:04:51+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-announces-appointment-of-dr-klaus-wagner-m-d-ph-d-as-chief-medical-officer/</loc>
<lastmod>2026-03-03T14:11:03+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-announces-appointment-of-dr-peter-lebowitz-m-d-ph-d-to-its-board-of-directors/</loc>
<lastmod>2026-03-03T14:13:29+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-announces-multi-target-collaboration-with-novo-nordisk-to-discover-novel-molecular-glue-degraders-for-cardiometabolic-and-rare-diseases/</loc>
<lastmod>2026-03-03T14:15:53+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-inc-announces-appointment-of-chief-financial-officer/</loc>
<lastmod>2026-03-03T14:18:10+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/in-the-media/guggenheim-healthcare-talks-targeted-protein-degradation-day/</loc>
<lastmod>2026-03-03T14:23:12+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-inc-to-participate-in-upcoming-guggenheim-healthcare-talks-targeted-protein-degradation-day/</loc>
<lastmod>2026-03-03T14:24:28+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/philip-chamberlain-named-as-chief-executive-officer-of-neomorph/</loc>
<lastmod>2026-03-03T14:27:33+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-inc-announces-109-million-series-a-financing-to-advance-proprietary-protein-degradation-platform-and-programs/</loc>
<lastmod>2026-03-03T14:29:21+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-announces-closing-of-100-million-series-b-financing/</loc>
<lastmod>2026-04-15T15:51:27+00:00</lastmod>
</url>			<url>
<loc>https://neomorph.com/press-release/neomorph-to-highlight-progress-in-targeted-protein-degradation-science-at-the-american-association-for-cancer-research-annual-meeting/</loc>
<lastmod>2026-04-15T16:22:33+00:00</lastmod>
</url>	</urlset>